Source: World Economic Forum (video statements)
China is the second-largest developer of new medicines, with its companies running an increasing share of the world’s clinical trials. It is also rising to the top in several critical areas of research, including cancer.
As discovery accelerates, what will faster and more competitive drug development mean for patients and how will it affect the prices they pay?